Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

Babies under 8 months old are eligible to get an RSV vaccine, and women who are pregnant can also get it to protect kids before they're born. The vaccine is available now through March. If you have ...

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

The company is now expecting 2025 revenue to range from $1.5 billion to $2.5 billion, with a midpoint of $2.0 billion, while FactSet is expecting $2.4 billion. Most of that will come in the second ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

As reports swirl about a “quademic” sweeping the nation, it can feel like every virus is peaking at once as Americans sniffle ...

Influenza, COVID-19 and RSV are staples of the winter cold and flu season, but the measles, whooping cough and norovirus are ...

While levels of one respiratory virus have reduced significantly in NC since January, the risk of contracting a respiratory ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...